ID
13096
Description
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00195663
Link
https://clinicaltrials.gov/show/NCT00195663
Keywords
Versions (1)
- 1/15/16 1/15/16 -
Uploaded on
January 15, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Early Rheumatoid Arthritis NCT00195663
Eligibility Early Rheumatoid Arthritis NCT00195663
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
diagnosis age
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0011900
- UMLS CUI [1,2]
- C0001779
Description
dmard
Data type
boolean
Alias
- UMLS CUI [1]
- C0242708
Description
anti-tumor necrosis factor
Data type
boolean
Alias
- UMLS CUI [1]
- C0281481
Description
wheelchair bedridden
Data type
boolean
Alias
- UMLS CUI [1]
- C0043143
- UMLS CUI [2]
- C0741453
Description
unsuitable
Data type
boolean
Alias
- UMLS CUI [1]
- C3844399
Description
pregnancy, breastfeeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Early Rheumatoid Arthritis NCT00195663
- StudyEvent: Eligibility
C0018759 (UMLS CUI [2])
C0262926 (UMLS CUI [3])
C0001779 (UMLS CUI [1,2])
C0741453 (UMLS CUI [2])
C0006147 (UMLS CUI [2])